AMPHASTAR PHARMACEUTICALS, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • May 20th, 2014 • Amphastar Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Indemnification Agreement (“Agreement”) is made and entered into as of the day of , 20 , by and between AMPHASTAR PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and (“Indemnitee”).
Employment AgreementEmployment Agreement • May 20th, 2014 • Amphastar Pharmaceuticals, Inc. • Pharmaceutical preparations • California
This Employment Agreement (the “Agreement”) is made as of May 19, 2014 between Amphastar Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Marilyn Purchase (the “Executive”).
DISTRIBUTION AGREEMENTDistribution Agreement • May 20th, 2014 • Amphastar Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
DISTRIBUTION AGREEMENT, dated as of May 2, 2005, by and between Amphastar Pharmaceuticals, Inc., a Delaware corporation (“Seller”) and Andrx Pharmaceuticals, Inc., a Florida corporation (“Purchaser”).
LOAN AGREEMENTLoan Agreement • May 20th, 2014 • Amphastar Pharmaceuticals, Inc. • Pharmaceutical preparations • California
THIS LOAN AGREEMENT (this “Agreement”), dated as of April 22, 2014, is entered into between CATHAY BANK, a California banking corporation (“Lender”), on the one hand, and AMPHASTAR PHARMACEUTICALS, INC., a Delaware corporation (“Borrower”), on the other hand, with reference to the following facts:
REVOLVING LOAN AND SECURITY AGREEMENT by and between AMPHASTAR PHARMACEUTICALS, INC., a Delaware corporation, and CATHAY BANK, a California banking corporation Dated as of April 10, 2012Revolving Loan and Security Agreement • May 20th, 2014 • Amphastar Pharmaceuticals, Inc. • Pharmaceutical preparations • California
THIS REVOLVING LOAN AND SECURITY AGREEMENT (“Agreement”) is entered into as of the above date between CATHAY BANK, a California banking corporation (“Lender”), with offices at 9650 Flair Drive, El Monte, California 91731, and AMPHASTAR PHARMACEUTICALS, INC., a Delaware corporation (“Borrower”), whose chief executive office is located at 11570 6th Street, Rancho Cucamonga, California 91730 (“Borrower’s Address”).
Transfer Contract for the Right to the Use of State-owned Land NKTZHZ [2009] No. (012)Transfer Contract for the Right to the Use of State-Owned Land • May 20th, 2014 • Amphastar Pharmaceuticals, Inc. • Pharmaceutical preparations
Pursuant to the Interim Regulations of the People’s Republic of China Concerning the Assignment and Transfer of the Right to the Use of State-owned Land in the Urban Areas and other relevant laws and regulations, the two parties are hereby entering into this contract regarding the transfer and assignment of the right to the use of state-owned land by following the principles of being equal, voluntary, fair and mutually beneficial with thorough consultation.
Transfer Contract for the Right to the Use of State-owned Land NKTZHZ [2010] No. (016)Transfer Contract for the Right to the Use of State-Owned Land • May 20th, 2014 • Amphastar Pharmaceuticals, Inc. • Pharmaceutical preparations
Pursuant to the Interim Regulations of the People’s Republic of China Concerning the Assignment and Transfer of the Right to the Use of State-owned Land in the Urban Areas and other relevant laws and regulations, the two parties are hereby entering into this contract regarding the transfer and assignment of the right to the use of state-owned land by following the principles of being equal, voluntary, fair and mutually beneficial with thorough consultation.
LONG-TERM SUPPLY AGREEMENTLong-Term Supply Agreement • May 20th, 2014 • Amphastar Pharmaceuticals, Inc. • Pharmaceutical preparations • California
This Supply Agreement (this “Agreement”) dated the 30th of November, 2008, is by and between Qingdao Jiulong Biopharmaceutical Co., Ltd. located at Qingdao Jiulong Industrial Area, Jiaozhou, Qingdao, Shandong, P.R. China, 266319 (the “Supplier”) and International Medication Systems, Ltd. located at 1886 Santa Anita Avenue, South El Monte, California 91733 (the “Buyer”).
Agreement Concerning Investment of Amphastar Nanjing Pharmaceuticals Co., Ltd. in Innovative Electronic Medical Equipment Project Date: July 5, 2010 Location: NanjingInvestment Agreement • May 20th, 2014 • Amphastar Pharmaceuticals, Inc. • Pharmaceutical preparations
The Nanjing Economic and Technological Development Zone (hereinafter referred to as “Development Zone”) is a state-level economic and technological developmental zone officially recognized by the State Council. The Management Committee of the Nanjing Economic and Technological Development Zone (hereinafter referred to as the “Management Committee”) is an agency assigned by the Nanjing Municipal Government and granted full administrative power over the Nanjing Economic and Technological Development Zone.
REGISTRATION RIGHTS AGREEMENT Dated as of February 4, 2005 between AMPHASTAR PHARMACEUTICALS, INC. and LOTUS CHINA FUND, L.P.Registration Rights Agreement • May 20th, 2014 • Amphastar Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
THIS REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is made as of the 4th day of February, 2005, by and between Amphastar Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Lotus China Fund, L.P. a Cayman Islands limited partnership (the “Investor”).
ASSET PURCHASE AGREEMENT (LONG FORM) AMONG DIOSYNTH FRANCE (AS SELLER) AMPHASTAR FRANCE PHARMACEUTICALS SAS (AS BUYER) AND SCHERING-PLOUGH April 30, 2014Asset Purchase Agreement • May 20th, 2014 • Amphastar Pharmaceuticals, Inc. • Pharmaceutical preparations
NOW, THEREFORE, in consideration of the mutual covenants, representations and warranties herein contained and intending to be legally bound hereby, the Parties hereto hereby agree as follows:
